...
机译:Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: Data mining of the FDA adverse event reporting system
Research Division of Clinical Pharmacology,First Affiliated Hospital of Nanjing Medical University;
Department of Respiratory,Wuxi No.5 People's Hospital;
Department of Urology,Shanghai Children's Hospital, Shanghai Jiao Tong University;
adverse event; disproportionality analyses; FDA adverse event reporting system; PCSK9 inhibitors; reporting odds ratio;